三叶草生物-B2023 中期报告

（於開曼群島註冊成立的有限公司）股份代號：2197 2023中期報告 目錄表 2公司資料4財務摘要6業務摘要7管理層討論與分析21其他資料44獨立審閱報告45中期簡明綜合損益表46中期簡明綜合全面收益表47中期簡明綜合財務狀況表49中期簡明綜合權益變動表51中期簡明綜合現金流量表53中期簡明綜合財務資料附註82釋義 Brian KREX20233 3120233 31 Donna Marie AMBROSINORalf Leo CLEMENS PO Box 309, Ugland HouseGrand Cayman, KY1-1104Cayman Islands Jeffrey FARROWThomas LEGGETT 1598-160149 Thomas LEGGETTJeffrey FARROW 33191901 Maples Fund Services (Cayman) LimitedPO Box 1093, Boundary HallCricket SquareGrand CaymanKY1-1102Cayman Islands Thomas LEGGETT 183171712-1716 2197 www.cloverbiopharma.com 202111 5 1526 97927 202212 311,856.5333.620236 301,522.9 20226 3011.82,499.020236 302,510.820236 30CEPI2,494.1 20236 3022.5 20226 30225.3115.851%2023630109.5 20226 30855.3469.755%20236 30385.6SCB-2019CpG 1018CMC 20226 3065.11,265.81,330.91,236.7 20226 301,136.120236 30650.6CEPI50% •20232AdimFlu-S (QIS)•AdimFlu-S (QIS)20232023AdimFlu-S(QIS)2023•AdimFlu-S (QIS)AdimFlu-S (QIS) •2023 •2895% •20237Trimer-TagPreFRSVoRSV PreF2023•2023IIIIIPCV SCB-2019CpG 1018Trimer-TagTrimer-TagTrimer-TagICTrimer-Tag Trimer-TagRSV2023 RSVPCV AdimFlu-S (QIS) 20232AdimFlu-S (QIS)AdimFlu-S(QIS) •AdimFlu-S (QIS)AdimFlu-S (QIS)2022 1 •AdimFlu-S (QIS)20232023AdimFlu-S (QIS)2023 RSV SCB-1019Trimer-TagPreFRSV •RSV PreF2023 •Trimer-TagRSVRSVoPreFRSV PreFSCB-1019ØV IV III II ISCB-1019 oSCB-1019RSV ARSV BRSVoSCB-1019oSCB-1019Trimer-TagGMP •2023•2895%•20232023 XBB XBB.1.52023 SCB-219M SCB-219MTPOFc(CIT)TPOSCB-219M(ADA)2023 2023IIIIIPCVA71(EV71) 20236 30200 GMP •20235•AdimFlu-S (QIS)2023CSOAdimFlu-S (QIS)•(1)(2) 2023Trimer-TagRSVAdimFlu-S (QIS)RSV2023PCVA71(EV71) 18A.08(3) SCB-2019CpG 10182023220236 300.32895% CEPI 20226 3011.82,499.020236 302,510.8CEPI2,494.12020CEPI(COVID-19)Outbreak Response To Novel Coronavirus (COVID-19)2022CEPI20236 30CEPI20 20236 3022.5 (i)(ii)(iii)(iv)(v) 20226 30225.3115.851%20236 30109.587.92022 (i)(ii)(iii)(iv)CDMO(v) 20226 30855.3469.755%20236 30385.6(i) SCB-2019CpG 1018CMCCDMO(ii) 20226 3065.11,265.820236 301,330.91,236.72023 (i)(ii) 20226 302.29.520236 3011.7 20226 301,136.120236 30650.6 20236 30202212 311,856.5333.61,522.92024 20236 302,805.61,522.90.698.61,169.114.4 20236 302,367.31,605.3226.3101.923.8410.0 20236 30410.03.95%6.81983% 20236 3020236 30 20236 30 100%20236 30 20236 3016.2202212 3122.15.9 20236 30238.8 20236 3068120236 30239.620236 30 20214 1520219 26D. 20236 30XV352 (1)20236 30(2)(3)20213 16(4)20236 30(5)20236 30(6)20236 301,294,002,733 20236 30 20236 30XV235% (1)AUT-XXI Hong Kong Holdings LimitedAUT-XXIAUT-XXI Holdings LimitedAUT HoldingAUT HoldingHH IMV Holdings, L.P.HH IMVHH IMVHillhouse Fund IV, L.P.Hillhouse FundHillhouseInvestment Management, Ltd.Hillhouse InvestmentAUT HoldingHH IMVHillhouse FundHillhouse Investment HH IMV Holdings GP, Ltd.AUT-XXI JNRY V Holdings LimitedJNRYHillhouse InvestmentHillhouse InvestmentHH IMV Holdings GP, Ltd.JNRY (2)99%42%58% 20236 3030,660,00070% (3)IIIIIIIVIVIV (4)20236 301,294,002,733 20236 30336 18 13.51B (1)20234 202022 Jeffrey FARROWTarsus Pharmaceuticals, Inc.TARS20234 24 20233 31Brian KREX20233 3120233 31 20233 31 3.21Thomas LeggettJeffrey FarrowThomas LeggettJeffrey Farrow3.10(2)3.21 20236 302410 13.2013.2113.22 20214 15 (a) (b) (i)(ii)(iii)(iv) (c) 25,947,096 (d) (e) (f) 20236 30 (1)(2)(3)20236 301,294,002,733 20214 1520219 26 (a) (b) (i)(ii)(iii)(iv) (c) 77,350,0005.97% (d) (e) (a)(b) (5) (f) 10202141520219 268 (g) 20236 3010520,256,95920236 30 (7)(25%)20236 15(8)(i)1/4825%75%(ii)1/48(9)(i)(25%)(ii)(25%)202312 1(10)(25%)20234 1(75%)(11)(12)20223 3120225 1220227 19202212 1520234 116.993.113.623.51.6520223 3120225 1220227 19202212 1520234 116.92.823.643.241.821.99(13)202212 1620231 31(14)(15)(16)20235 302023 32,018,83330,459,837 20219 26 (a) (b) (i)(ii)(iii)(iv) (c) 1,158,114,723115,811,47210%115,751,136(i)(ii)8.94% (d) 121%12 (e) (f) (i)(ii)(iii) (g) 20219 2610810 (h) 20236 3020449,915,24620236 30 (1)20223 3120225 1220227 19202212 1520234 116.993.113.623.51.6520223 3120225 1220227 19202212 1520234 114.151.242.231.600.99(2)10(3)20236 301,294,002,733(4)20225 520225(5)(6)(25%)20236 15(7)20234 1(8)(i)1/4825%75%(ii)1/48(9)(i)(25%)(ii)(25%)202312 1(10)(25%)20234 1(75%)(11)(12)(13)20235 302023 81,066,82765,835,890 1.52% 202111 51,884.31,549.020236 3073.2% 20238 222023822415.2 1. 2. COVID-1951.9XBB.1.5SCB-808SCB-313COVID-19(i)RSV(ii)(iii) 202212 6202212 13202212 6128,000,000202212 13500.5202363078.5% 20238 22202382269.420236 3020238 22 1. SCB-2019CpG 101869.4 20236 30 Ernst & Young27/F, One Taikoo Place979 King’s RoadQuarry Bay, Hong Kong 458120236 30343434 2410 34 20238 22 1. 201810 31PO Box 309, UglandHouse, Grand Cayman, KY1-1104, CaymanIslands 202111 5 2. 20236 3034202212 31 20236 308,851,105,00020236 30 (a)20236 301,264,455,000438,247,000 (b) 3. 202212 31 171717 179 1281212 (a)1220231 1 (b)820231 1 3. (c)121220221 120221 1 (i)(ii)20221 1 12 (d)1220231 1202312 3